Secondary amyloidosis in the hydrops lesion of a patient with pellucid marginal degeneration

Hugo Y Hsu1, Nancy J Phillips, George J Harocopos

  • 1Department of Ophthalmology, St. Louis University School of Medicine, St. Louis, MO, USA.

Cornea
|August 28, 2007
PubMed
Abstract

Insights

This study reports a rare case of secondary corneal amyloidosis in a patient with pellucid marginal degeneration (PMD). The condition developed in a chronic hydrops lesion, highlighting a unique corneal response to injury.

Area of Science:

  • Ophthalmology
  • Pathology

Background:

  • Pellucid marginal degeneration (PMD) is a rare, progressive corneal thinning disorder.
  • Corneal hydrops, characterized by stromal edema, can occur in PMD.
  • Secondary corneal amyloidosis is an uncommon deposition of amyloid in the cornea.

Observation:

  • A 63-year-old male with PMD developed persistent acute hydrops.
  • The hydrops evolved into an elevated, gelatinous lesion with neovascularization.
  • Histopathological examination of the excised cornea revealed amyloid deposits.

Findings:

  • The excised corneal button showed significant subepithelial amyloid deposits.
  • Amyloid deposition was associated with a disrupted Descemet membrane.
  • This confirmed the diagnosis of secondary corneal amyloidosis in the context of chronic hydrops in PMD.

Implications:

  • This case represents the first documented instance of significant secondary amyloidosis in a chronic hydrops lesion associated with PMD.
  • Secondary corneal amyloidosis may be an underdiagnosed complication of chronic corneal injury.
  • Further research is warranted to understand the pathogenesis and clinical significance of this condition.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...